Molecules (Feb 2021)

s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation

  • Anamika Sharma,
  • Rotimi Sheyi,
  • Beatriz G. de la Torre,
  • Ayman El-Faham,
  • Fernando Albericio

DOI
https://doi.org/10.3390/molecules26040864
Journal volume & issue
Vol. 26, no. 4
p. 864

Abstract

Read online

This review provides an overview of the broad applicability of s-triazine. Our many years working with this intriguing moiety allow us to discuss its wide activity spectrum (inhibition against MAO-A and -B, anticancer/antiproliferative and antimicrobial activity, antibacterial activity against MDR clinical isolates, antileishmanial agent, and use as drug nano delivery system). Most of the compounds addressed in our studies and those performed by other groups contain only N-substitution. Exploiting the concept of orthogonal chemoselectivity, first described by our group, we have successfully incorporated different nucleophiles in different orders into s-triazine core for application in peptides/proteins at a temperature compatible with biological systems.

Keywords